Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.59 |
| ▸ | ERN1 | O75460 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | F2 | P00734 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 2/20 | 0.37 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.37 |
| ▸ | SI | P14410 | 2/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.37 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8835833 | 0.86 | KCNMA1 (0.59) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL3969778 | 0.80 | KCNMA1 (0.78) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL9238836 | 0.78 | KCNMA1 (0.64) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL8445816 | 0.77 | KCNMA1 (0.62) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL8431460 | 0.75 | KMT2A (0.59) | KCNMA1KMT2APOLBATMSMN1; SMN2 | |
| SCHEMBL80393 | 0.75 | KCNMA1 (1.00) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL11696314 | 0.74 | KCNMA1 (0.51) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL18780221 | 0.74 | KCNMA1 (0.58) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL9616134 | 0.74 | KCNMA1 (0.55) | KCNMA1RAB9AKMT2APOLBMAPK1 | |
| SCHEMBL23840194 | 0.72 | KCNMA1 (0.64) | KCNMA1RAB9AKMT2APOLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197460-B1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2022-04-20 | — | — | EP | disclosed |
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | GREENPHARMA SAS (FR) | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281653-A1 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOKINES | CCL2, CCL11, CCL5 | KCNMA1 4182/4885ERN1 4494/4885RAB9A 3377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.